Literature DB >> 15705304

Human embryonic stem cell lines with genetic disorders.

Y Verlinsky1, N Strelchenko, V Kukharenko, S Rechitsky, O Verlinsky, V Galat, A Kuliev.   

Abstract

A previous study described the establishment of human embryonic stem cell (ESC) lines from different sources of embryonic material, including morula, whole blastocyst and isolated inner cell mass. Using these methods, a repository of ESC lines has been established with different genetic abnormalities, which provides an unlimited source of disease cells in culture for undertaking research on the primary disturbances of the cellular processes in the genetically abnormal cells. ESC lines with genetic disorders were derived from the mutant embryos detected and avoided from transfer in the ongoing practice of preimplantation genetic diagnosis (PGD). The current repository contains 18 ESC lines with genetic disorders, including adrenoleukodystrophy, Duchenne and Becker muscular dystrophy, Fanconi anaemia, complementation group A, fragile-X syndrome, Huntington disease (three lines), Marfan syndrome, myotonic dystrophy (two lines), neurofibromatosis type I (five lines) and thalassaemia (two lines). These ESC lines are presently used for research purposes and may be available on request.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15705304     DOI: 10.1016/s1472-6483(10)60810-3

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  55 in total

Review 1.  Induced pluripotent stem cells--opportunities for disease modelling and drug discovery.

Authors:  Marica Grskovic; Ashkan Javaherian; Berta Strulovici; George Q Daley
Journal:  Nat Rev Drug Discov       Date:  2011-11-11       Impact factor: 84.694

Review 2.  Amniotic fluid stem cell-based models to study the effects of gene mutations and toxicants on male germ cell formation.

Authors:  Claudia Gundacker; Helmut Dolznig; Mario Mikula; Margit Rosner; Oliver Brandau; Markus Hengstschläger
Journal:  Asian J Androl       Date:  2012-01-09       Impact factor: 3.285

3.  Vitrified blastocysts from Preimplantation Genetic Diagnosis (PGD) as a source for human Embryonic Stem Cell (hESC) derivation.

Authors:  Begoña Aran; Miquel Sole; Ignasi Rodriguez-Pizà; Mònica Parriego; Yolanda Muñoz; Montserrat Boada; Pere N Barri; Juan Carlos Izpisúa; Anna Veiga
Journal:  J Assist Reprod Genet       Date:  2012-06-27       Impact factor: 3.412

Review 4.  Non-embryo-destructive Extraction of Pluripotent Embryonic Stem Cells: Implications for Regenerative Medicine and Reproductive Medicine.

Authors:  R Dittrich; M W Beckmann; W Würfel
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-12       Impact factor: 2.915

5.  Analysis of expression of genes specific for pluripotent and primordial germ cells in human and mouse embryonic stem cell lines.

Authors:  O F Gordeeva; N Y Krasnikova; A V Larionova; T A Krylova; G G Polyanskaya; R D Zinov'eva; D V Gulyaev; M V Pryzhkova; N N Nikol'skii; N G Khrushchov
Journal:  Dokl Biol Sci       Date:  2006 Jan-Feb

6.  Induced pluripotent stem cell technology for the study of human disease.

Authors:  Gabsang Lee; Lorenz Studer
Journal:  Nat Methods       Date:  2010-01       Impact factor: 28.547

7.  Female sex bias in human embryonic stem cell lines.

Authors:  Dalit Ben-Yosef; Ami Amit; Mira Malcov; Tsvia Frumkin; Ahmi Ben-Yehudah; Ido Eldar; Nava Mey-Raz; Foad Azem; Gheona Altarescu; Paul Renbaum; Rachel Beeri; Irit Varshaver; Talia Eldar-Geva; Silvina Epsztejn-Litman; Ephrat Levy-Lahad; Rachel Eiges
Journal:  Stem Cells Dev       Date:  2011-06-24       Impact factor: 3.272

8.  Establishment and characterization of human embryonic stem cell lines, Turkey perspectives.

Authors:  Zafer Nihat Candan; Semra Kahraman
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-03-27       Impact factor: 2.416

9.  The DNA replication program is altered at the FMR1 locus in fragile X embryonic stem cells.

Authors:  Jeannine Gerhardt; Mark J Tomishima; Nikica Zaninovic; Dilek Colak; Zi Yan; Qiansheng Zhan; Zev Rosenwaks; Samie R Jaffrey; Carl L Schildkraut
Journal:  Mol Cell       Date:  2013-11-27       Impact factor: 17.970

Review 10.  Modeling Huntington's disease with induced pluripotent stem cells.

Authors:  Julia A Kaye; Steven Finkbeiner
Journal:  Mol Cell Neurosci       Date:  2013-02-28       Impact factor: 4.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.